1. Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, et al.; ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991-1003. https://doi.org/10.1097/MPG.0000000000001594 https://pubmed.ncbi.nlm.nih.gov/28541262 
2. Homan M, Hojsak I, Kolaček S. Helicobacter pylori in pediatrics. Helicobacter. 2012;17:43-8. https://doi.org/10.1111/j.1523-5378.2012.00982.x https://pubmed.ncbi.nlm.nih.gov/22958155 
3. Sierra MS, Hastings EV, Goodman KJ. What do we know about benefits of H. pylori treatment in childhood? Gut Microbes. 2013;4(6):549-67. https://doi.org/10.4161/gmic.27000 https://pubmed.ncbi.nlm.nih.gov/24280768 
4. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143-53. https://doi.org/10.1136/gut.2009.192757 https://pubmed.ncbi.nlm.nih.gov/20525969 
5. Spee LA, Madderom MB, Pijpers M, van Leeuwen Y, Berger MY. Association between helicobacter pylori and gastrointestinal symptoms in children. Pediatrics. 2010;125(3):e651-69. https://doi.org/10.1542/peds.2010-0941 https://pubmed.ncbi.nlm.nih.gov/20156901 
6. Holster IL, Vila AM, Caudri D, den Hoed CM, Perez-Perez GI, Blaser MJ, et al. The impact of Helicobacter pylori on atopic disorders in childhood. Helicobacter. 2012;17(3):232-7. https://doi.org/10.1111/j.1523-5378.2012.00934.x https://pubmed.ncbi.nlm.nih.gov/22515362 
7. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, Demmelmair H, Ballauff A, Findeisen A, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2002;14(10):1119-23. https://doi.org/10.1097/00042737-200210000-00013 https://pubmed.ncbi.nlm.nih.gov/12362103 
8. Bontems P, Kalach N, Vanderpas J, Iwanczak B, Casswall T, Koletzko S, et al. Helicobacter pylori Infection in European children with gastro-duodenal ulcers and erosions. Pediatr Infect Dis J. 2013;32(12):1324-9. https://doi.org/10.1097/INF.0000000000000005 https://pubmed.ncbi.nlm.nih.gov/24569306 
9. Brito HS, Braga JA, Loggetto SR, Machado RS, Granato CF, Kawakami E. Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial. Platelets. 2015;26(4):336-41. https://doi.org/10.3109/09537104.2014.911836 https://pubmed.ncbi.nlm.nih.gov/24832381 
10. Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, et al.; AIEOP-ITP Study Group. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer. 2011;56(2):273-8. https://doi.org/10.1002/pbc.22770 https://pubmed.ncbi.nlm.nih.gov/20830773 
11. Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology. 2009;14(5):282-5. https://doi.org/10.1179/102453309X12473408860181 https://pubmed.ncbi.nlm.nih.gov/19843384 
12. Homan M, Luzar B, Kocjan BJ, Orel R, Mocilnik T, Shrestha M, et al. Prevalence and clinical relevance of cagA, vacA, and iceA genotypes of Helicobacter pylori isolated from Slovenian children. J Pediatr Gastroenterol Nutr. 2009;49(3):289-96. https://doi.org/10.1097/MPG.0b013e31818f09f2 https://pubmed.ncbi.nlm.nih.gov/19525870 
13. Homan M, Šterbenc A, Kocjan BJ, Luzar B, Zidar N, Orel R, et al. Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slovenian children. Antonie van Leeuwenhoek. 2014;106(4):637-45. https://doi.org/10.1007/s10482-014-0234-0 https://pubmed.ncbi.nlm.nih.gov/25055876 
14. Thankachan P, Muthayya S, Sierksma A, Eilander A, Thomas T, Duchateau GS, et al. Helicobacter pylori infection does not influence the efficacy of iron and vitamin B(12) fortification in marginally nourished Indian children. Eur J Clin Nutr. 2010;64(10):1101-7. https://doi.org/10.1038/ejcn.2010.126 https://pubmed.ncbi.nlm.nih.gov/20683455 
15. Goodman KJ, Correa P, Mera R, Yepez MC, Cerón C, Campo C, et al. Effect of Helicobacter pylori infection on growth velocity of school-age Andean children. Epidemiology. 2011;22(1):118-26. https://doi.org/10.1097/EDE.0b013e3181fe7e31 https://pubmed.ncbi.nlm.nih.gov/21068668 
16. Rimbara E, Sasatsu M, Graham DY. PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013;943:279-87. https://doi.org/10.1007/978-1-60327-353-4_19 https://pubmed.ncbi.nlm.nih.gov/23104297 
17. Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R, Torres J. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta-analysis. Helicobacter. 2011;16(4):327-37. https://doi.org/10.1111/j.1523-5378.2011.00863.x https://pubmed.ncbi.nlm.nih.gov/21762274 
18. Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12(2):177-86.e3. 
19. Butenko T, Jeverica S, Orel S, Homan M. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian childrene. Helicobacter. 2017;22(5):e12400. https://doi.org/10.1111/hel.12400 https://pubmed.ncbi.nlm.nih.gov/28653787 
20. Schwarzer A, Bontems P, Urruzuno P, Kalach N, Iwanczak B, Roma-Giannikou E, et al. Sequential Therapy for Helicobacter pylori Infection in Treatment-naïve Children. Helicobacter. 2016;21(2):106-13. https://doi.org/10.1111/hel.12240 https://pubmed.ncbi.nlm.nih.gov/26123402 
21. Tepeš B, Vujasinović M, Šeruga M, Stefanovič M, Forte A, Jeverica S. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2016;28(6):676-83. https://doi.org/10.1097/MEG.0000000000000590 https://pubmed.ncbi.nlm.nih.gov/26862930 
22. Jeverica S, Tepeš B, Ihan A, Skvarč M. Primarna odpornost bakterije Helicobacter pylori. Zdrav Vestn. 2010;79(1):25-30. 
23. Zhu R, Chen K, Zheng YY, Zhang HW, Wang JS, Xia YJ, et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. World J Gastroenterol. 2014;20(47):18013-21. https://doi.org/10.3748/wjg.v20.i47.18013 https://pubmed.ncbi.nlm.nih.gov/25548501 
24. Molina-Infante J, Lucendo AJ, Angueira T, Rodriguez-Tellez M, Perez-Aisa A, Balboa A, et al.; European Registry on H. pylori management (Hp‐EuReg). Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther. 2015;41(6):581-9. https://doi.org/10.1111/apt.13069 https://pubmed.ncbi.nlm.nih.gov/25776067 
25. Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al.; H pylori Working Groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53(2):230-43. https://pubmed.ncbi.nlm.nih.gov/21558964 
26. Schwarzer A, Bontems P, Urruzuno P, Kalach N, Iwanczak B, Roma-Giannikou E, et al. Sequential Therapy for Helicobacter pylori Infection in Treatment-naïve Children. Helicobacter. 2016;21(2):106-13. https://doi.org/10.1111/hel.12240 https://pubmed.ncbi.nlm.nih.gov/26123402 
27. Zeng M, Mao XH, Li JX, Tong WD, Wang B, Zhang YJ, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386(10002):1457-64. https://doi.org/10.1016/S0140-6736(15)60310-5 https://pubmed.ncbi.nlm.nih.gov/26142048 
